fda glp-1 warning 2025 november Pharmacovigilance analysis of neurological adverse events associated with receptor agonists based on the Adverse Event Reporting System Scam warning: GLP-1 shoppers warned

As of 2026, retatrutide has not been approved by the MHRA, FDA, EMA, or any other regulatory authority for human or veterinary use

2.4.4 The association between microplastics and central nervous system neoplasms Toxicological testing and metabolic profiling results demonstrate that nano/micron polystyrene materials (n/mPS) exert significant toxic effects on SH-SY5Y human neuroblastoma cells, with enhanced toxicity under oxidative conditions ultimately leading to cytotoxicity and metabolic disturbances (59), revealing microplastics intervention in tumor cells

Mua u

Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease

& Wachtveitl, J

This is why buying from brands that provide clear labelling and third-party testing matters: it is the main quality check available to consumers in the absence of pre-approval